Skip to main content
. Author manuscript; available in PMC: 2017 Aug 16.
Published in final edited form as: Br J Haematol. 2017 Mar 14;177(6):919–929. doi: 10.1111/bjh.14594

Table I.

Funding for Sickle Cell Disease for research, health and training (Selected funding).

Project Funding Source Period
Anaemia in SCD The Wellcome Trust, UK 2012–2016
H3ABioNET – Bioinformatics Award NIH – University of Cape Town 2012–2017
H3Africa Ethics in SCD NIH – University of Cape Town 2013–2017
mDOT University of Pittsburgh 2015–2017
Muhimbili Wellcome programme The Wellcome Trust, UK 2011–2016
Genomic research in SCD The Wellcome Trust – Sanger 2011–2015
Vascular Function in SCD The Wellcome Trust – LSHTM 2007–2014
Newborn screening for SCD HDIF, DFID 2015–2016
Sickle cell project University of Oxford, UK 2008–2010
Sickle cell study The Wellcome Trust, UK 2004–2007

DFID, Department for International Development; HDIF, Human Development Innovation Fund; LSHTM, London School of Hygiene and Tropical Medicine; mDOT, mobile-directly observed therapy for hydroxycarbamide use; NIH, National Institutes of Health; SCD, sickle cell disease.